Adria Cimino is an Amazon best-selling author and contributor. She covers a diverse range of topics including finance, trading, investment, and the intersection of technology with medicine and healthcare, particularly in areas like AI and financial technology. Adria's work has been featured in prominent publications such as Yahoo News, Nasdaq, and USA TODAY.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Adria's coverage primarily focuses on investment analysis and cites data, with a specific emphasis on healthcare & pharmaceutical industries. Based on this focus, she is likely to be receptive to pitches related to expert commentary or insights into stock market trends, investing strategies, and financial analysis within the healthcare and pharmaceutical sectors.
Given her articles' titles centered around specific stocks and investment opportunities, Adria could be interested in sources that provide detailed analysis of individual companies within the mentioned industries. Pitches offering unique perspectives on potential market trends or innovative approaches may capture her attention.
Although there is no specified geographic focus for Adria's coverage, it appears that she takes a broad international view of stock markets and investing opportunities.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By Adria Cimino – Jan 17, 2025 at 4:15AM Key Points Artificial intelligence drove market gains in 2024, but the momentum is far from over.
By: Adria Cimino
By Adria Cimino – Jan 18, 2025 at 4:08AM Key Points Nvidia scored a win in the first wave of artificial intelligence growth as it dominates the chip market.
By: Adria Cimino
Is Warren Buffett's Recent $610 Million Move a Positive Sign for Investors in 2025?
By Adria Cimino – Jan 18, 2025 at 6:15PM Key Points Stock splits lower a company's per-share price, making the stock more accessible to a broad range of investors.
By Adria Cimino – Jan 19, 2025 at 5:10AM Key Points Amazon stock has climbed over the past decade -- last year, it advanced 44%.
By: Adria Cimino
By Adria Cimino – Jan 19, 2025 at 12:30PM Key Points Comments from Nvidia's CEO about the quantum computing timeline spooked investors earlier this month -- and quantum computing stocks tumbled.
By: Adria Cimino
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
Got $500? 2 Pharmaceutical Stocks to Buy and Hold Forever
By: Adria Cimino
By Adria Cimino – Jan 22, 2025 at 4:10AM Key Points This company aims to enter a market that could top $100 billion by the end of the decade.
One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a class of drugs that's proven to be both efficacious and safe in clinical studies and in the real world. You might be familiar with the top sellers, such as Eli Lilly's Zepbound or Novo Nordisk's Wegovy -- they've made headlines as demand for them soared. The obesity drug market may reach beyond $100 billion by 2030, according to Morgan Stanley Research.
(833) 317-6278 
